Human Immunodeficiency Virus (HIV) infection impairs immune defenses and increases susceptibility to opportunistic infections and other diseases. To better define heterogeneity, functions, and regulatory mechanisms of immune cells across different viral load states, the authors reanalyzed an existing peripheral blood mononuclear cell (PBMC) single-cell RNA sequencing (scRNA-seq) dataset (GSE157829). The goal was to construct single-cell immune atlases for distinct viral-load profiles and to identify cell subpopulations, pathways, developmental trajectories, and transcriptional regulators associated with immune dysregulation in HIV.
The source dataset comprised PBMC scRNA-seq profiles from three people living with HIV with high viral load (HL-HIV), three people living with HIV with low viral load (LL-HIV), and one healthy control donor. The authors performed reanalysis of this publicly available dataset to map immune cell types and subpopulations and to examine differences tied to viral-load status. Specific preprocessing and analysis pipelines were not detailed in the abstract; those methodological specifics were not reported in the source text provided here.
Using the reanalyzed data, the investigators built single-cell immune atlases that represent the immune landscape under differing HIV viral-load profiles. These atlases were used to identify dynamic changes in abundance and transcriptional states of immune subpopulations and to infer signaling pathways and transcriptional regulators that may drive observed phenotypes.
At single-cell resolution, two non-classical monocyte subpopulations were highlighted: ncMono_LYN_TCF7L2 and ncMono_IL32. According to the reanalysis, these subpopulations serve roles in immunosurveillance yet concurrently activate pro-inflammatory pathways. The net effect described is contribution to immune activation, which may exacerbate immune dysregulation in the context of HIV infection with higher viral load.
A distinct B cell cluster labeled B_CD83 was identified as playing an important role in B cell development. The authors report that this subpopulation facilitates B cell differentiation and tolerance, suggesting its involvement in humoral immune competence and maintenance of self-tolerance amid HIV-associated perturbations.
One naive T cell subset, designated Naive.T_TNFAIP3, exhibited transcriptional features described as anti-inflammatory and protective against aberrant apoptosis. This suggests a potential role for the subpopulation in limiting inappropriate T cell loss and tempering inflammatory damage.
A central memory T (TCM) subpopulation defined as TCM_TCF7_CCR7 was implicated in regulating the expansion of HIV-specific CD8+ T cells and in maintaining aspects of the immune response. The presence and characteristics of this subpopulation were presented as relevant to adaptive immune control mechanisms during HIV infection.
A notable finding of the reanalysis was a significant enrichment of IFI44L-positive subpopulations across multiple cell types, with particularly higher representation in HL-HIV samples. Based on these observations, the authors nominate IFI44L as a potential disease hub gene in the setting of high HIV viral load and raise it as a candidate novel biomarker for HIV-associated immune dysregulation.
The report concludes that HIV infection increases the complexity of immune cell subpopulations detectable by scRNA-seq. Identification of subpopulation-specific functions and transcriptional regulators — and the cross-cell-type enrichment of IFI44L in high viral load samples — point to mechanistic pathways that could mediate immune activation and dysfunction in HL-HIV. The authors propose that IFI44L warrants further investigation as a marker and possible regulator of disease state.
The analysis is a reanalysis of a single publicly available dataset composed of three HL-HIV, three LL-HIV, and one healthy control donor. The source text does not report external experimental validation, functional assays, or larger cohort confirmation. Therefore, while hypotheses about subpopulation roles and IFI44L are generated, the source did not provide validation data; further work will be required to confirm these findings and to establish causal relationships or clinical utility.
Reanalysis of PBMC scRNA-seq data revealed altered immune-cell composition and transcriptional states associated with HIV viral-load status. Non-classical monocytes, specific B and T subpopulations, and enrichment of IFI44L in HL-HIV samples were highlighted as contributors to immune activation and dysregulation. The authors identify IFI44L as a potential hub gene and biomarker in high viral load HIV, while noting that additional validation was not reported in the source and is needed to translate these observations into mechanistic insight or clinical application.